1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Martin Schrappe: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 Blinatumomab, Bortezomib, Cyclophosphamide - Acute Lymphoblastic Leukemia, Pediatric | Phase 3 | Recruiting | Martin Schrappe | 5000 | 2018-07-15 | 2025-04-06 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Asparaginase (1) · Bortezomib (1) · Cyclophosphamide (1) · Cytarabine (1) · Daunorubicin (1) · Dexamethasone (1) · Doxorubicin (1) · Etoposide (1) · Ifosfamide (1) · Mercaptopurine (1) · Methotrexate (1) · Prednisolone (1) · Prednisone (1) · Thioguanine (1) · Vincristine (1)
Australia (1) · Austria (1) · Czechia (1) · Germany (1) · Israel (1) · Italy (1) · Slovakia (1) · Switzerland (1)